ERYTECH PHARMA And RALLYE On The List Of Winners And Losers Of Thursday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are ERYTECH PHARMA, AXA NV23, and ALAN ALLMAN. Financial Asset Price Change Updated (EST) ERYTECH PHARMA (ERYP.PA) 0.89 12.52% 2023-03-23 11:48:17 AXA NV23 (CSNV.PA) 28.66 11.69%…

Read More

ERYTECH PHARMA Stock 12.52% Up Today

(VIANEWS) – The Market ended the session with ERYTECH PHARMA (ERYP.PA) rising 12.52% to €0.89 on Thursday while CAC 40 rose 0.11% to €7,139.25. ERYTECH PHARMA’s last close was €0.80, 64.82% under its 52-week high of €2.26. About ERYTECH PHARMA ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and…

Read More

ERYTECH PHARMA And ATLANTIC SAPPHIRE On The List Of Winners And Losers Of Friday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are ERYTECH PHARMA, FIPP, and BASILIX CERT. Financial Asset Price Change Updated (EST) ERYTECH PHARMA (ERYP.PA) 0.76 11.44% 2023-03-17 11:48:21 FIPP (FIPP.PA) 0.15 10.61% 2023-03-17 08:50:39…

Read More

METABOLIC EXPLORER And DLTX On The List Of Winners And Losers Of Monday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are METABOLIC EXPLORER, LAVIDE HOLDING, and ERYTECH PHARMA. Rank Financial Asset Price Change Updated (EST) 1 METABOLIC EXPLORER (METEX.PA) 1.37 20.86% 2023-02-27 11:00:23 2 LAVIDE HOLDING…

Read More

ERYTECH PHARMA Stock 15.36% Up On Monday

(VIANEWS) – The Market ended the session with ERYTECH PHARMA (ERYP.PA) rising 15.36% to €0.89 on Monday while CAC 40 jumped 1.51% to €7,295.55. ERYTECH PHARMA’s last close was €0.77, 65.86% below its 52-week high of €2.26. About ERYTECH PHARMA ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and…

Read More